| Effect of major lifestyle risk factors, independent and jointly, on life expectancy with and without cardiovascular disease: results from the Consortium on Health and Ageing … MG O’Doherty, K Cairns, V O’Neill, F Lamrock, T Jørgensen, H Brenner, ... European journal of epidemiology 31, 455-468, 2016 | 109 | 2016 |
| Biological misinterpretation of transcriptional signatures in tumor samples can unknowingly undermine mechanistic understanding and faithful alignment with preclinical data NC Fisher, RM Byrne, H Leslie, C Wood, A Legrini, AJ Cameron, ... Clinical Cancer Research 28 (18), 4056-4069, 2022 | 16 | 2022 |
| A retrospective analysis of budget impact models submitted to the National Centre for Pharmacoeconomics in Ireland F Lamrock, L McCullagh, L Tilson, M Barry The European Journal of Health Economics 21, 895-901, 2020 | 8 | 2020 |
| Health technology assessment of drugs in Ireland: an analysis of timelines E Connolly, H O’Donnell, F Lamrock, L Tilson, M Barry PharmacoEconomics-open 4, 287-296, 2020 | 7 | 2020 |
| Difficulties arising in reimbursement recommendations on new medicines due to inadequate reporting of population adjustment indirect comparison methods EM Holmes, J Leahy, CD Walsh, A White, PT Donnan, F Lamrock Research Synthesis Methods 10 (4), 615-617, 2019 | 5 | 2019 |
| Extensions of health economic evaluations in R for Microsoft Excel users: a tutorial for incorporating heterogeneity and conducting value of information analyses NR Naylor, J Williams, N Green, F Lamrock, A Briggs PharmacoEconomics 41 (1), 21-32, 2023 | 4 | 2023 |
| Health economic evaluation using Markov models in R for Microsoft excel users: a tutorial N Green, F Lamrock, N Naylor, J Williams, A Briggs Pharmacoeconomics 41 (1), 5-19, 2023 | 3 | 2023 |
| Improving Parameter Estimation For A Decision-Analytic Markov Model To Evaluate The Use Of Novel Biomarker Led Strategies For Prevetion Of Cardiovascular Disease F Lamrock, K Cairns, F Kee, A Conrads-Frank, P Schnell-Inderst, ... Value in Health 18 (3), A13, 2015 | 3 | 2015 |
| To HTA or not to HTA: identifying the factors influencing the rapid review outcome in Ireland H O’Donnell, F Lamrock, L Tilson, M Barry Value in Health 23 (2), 274-275, 2020 | 2 | 2020 |
| OP97 Cost-effectiveness Model Appraisal Guidelines For Health Technology Assessments In Ireland F Lamrock, J O'Connor, J Leahy, C Gorry, L Tilson, M Barry International Journal of Technology Assessment in Health Care 35 (S1), 24-25, 2019 | 2 | 2019 |
| Using a multi-state modelling (MSM) approach to predict dairy calf health status using on-farm precision technology data E Chisholm, G Scoley, F Lamrock The Challenge of Change-The New Normal?, 85, 2021 | 1 | 2021 |
| Evaluation of Gene Set Enrichment Analysis (GSEA) tools highlights the value of single sample approaches over pairwise for robust biological discovery. C Bull, RM Byrne, NC Fisher, SM Corry, R Amirkhah, J Edwards, L Hillson, ... bioRxiv, 2024.03. 15.585228, 2024 | | 2024 |
| Deterministic modelling of asymptomatic spread and disease stage progression in vaccine preventable infectious diseases G Kiss, S Moutari, C McTaggart, L Patterson, F Kee, F Lamrock Quantitative Biology, 2024 | | 2024 |
| A comparison of international modelling methods to evaluate health economics of colorectal cancer screening: a systematic review protocol O Adair, E McFerran, T Owen, C McKee, F Lamrock, M Lawler Systematic Reviews 12 (1), 14, 2023 | | 2023 |
| RWD69 The Impact of COVID-19 on Colorectal Cancer Screening in Northern Ireland Z Waller, E McFerran, F Lamrock, M Lawler, F Bannon Value in Health 25 (7), S589, 2022 | | 2022 |
| Imputing Missing Confidential Data without the use of Multiple Imputation O Adair, F Lamrock, M Lawler, E McFerran Conference for Applied Statistics in Ireland, 2022, 2022 | | 2022 |
| Budget impact models in Ireland F Lamrock PharmacoEconomics & Outcomes News 851, 5-18, 2020 | | 2020 |
| Cost-Effectiveness Model Appraisal Guidelines For HTAs in Ireland. F Lamrock, J O'Connor, J Leahy, C Gorry, L Tilson, M Barry International Journal of Technology Assessment in Health Care 35 (S1), 2019 | | 2019 |
| PCN73 ECONOMIC EVALUATION OF TARGETED TREATMENTS FOR BRAFV600 POSITIVE MELANOMA IN THE IRISH HEALTHCARE SETTING C Gorry, J Leahy, F Lamrock, M Barry, L McCullagh Value in Health 22, S449, 2019 | | 2019 |
| pcn184 economic evaluation of checkpoint inhibitors for the treatment of advanced melanoma in the irish healthcare setting C Gorry, J Leahy, F Lamrock, M Barry, L McCullagh Value in Health 22, S471-S472, 2019 | | 2019 |
